A Drug-Induced Acute Pancreatitis Retrospective Study

Background and Aims. Drugs are considered a relatively rare and understudied cause of acute pancreatitis (AP). The lack of convincing and conclusive data on drug-induced AP (DIAP) complicates the diagnosis as well as the identification of the causative drug. The aim of this study is to document caus...

Full description

Saved in:
Bibliographic Details
Main Authors: Ann-Lorie Gagnon, Alexandre Lavoie, Marie-Pier Frigon, Alban Michaud-Herbst, Karine Tremblay
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Canadian Journal of Gastroenterology and Hepatology
Online Access:http://dx.doi.org/10.1155/2020/1516493
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832567463649214464
author Ann-Lorie Gagnon
Alexandre Lavoie
Marie-Pier Frigon
Alban Michaud-Herbst
Karine Tremblay
author_facet Ann-Lorie Gagnon
Alexandre Lavoie
Marie-Pier Frigon
Alban Michaud-Herbst
Karine Tremblay
author_sort Ann-Lorie Gagnon
collection DOAJ
description Background and Aims. Drugs are considered a relatively rare and understudied cause of acute pancreatitis (AP). The lack of convincing and conclusive data on drug-induced AP (DIAP) complicates the diagnosis as well as the identification of the causative drug. The aim of this study is to document causes of DIAP cases that occurred in the Saguenay-Lac-Saint-Jean (SLSJ) population. Methods. We have conducted a retrospective and descriptive population-based study of DIAP cases that occurred between 2006 and 2014 in the six hospitals serving the entire SLSJ population. Cases were selected from the Quebec Ministry of Health hospitalizations registry (MED-ECHO) administrative public database. A medical chart review was performed in an attempt to characterize DIAP hospitalizations and to identify the imputable drugs. Results. During the studied period, 75 cases (30.7% male, 69.3% female) were included totaling 90 hospitalizations for DIAP. Among them, 50 causative drugs were identified and were distributed in 17 different drug classes. Recurrent DIAPs were documented in 13 cases, and among them, 6 cases have experimented a positive rechallenge. Six drugs (5-fluorouracil, atorvastatin, bortezomib, nilotinib, rosuvastatin, and triamcinolone) were associated with the highest degree of evidence. The most common causative drugs of DIAP hospitalization were azathioprine (n = 7), followed by atorvastatin (n = 6), hydrochlorothiazide (n = 5), rosuvastatin (n = 4), and codeine (n = 4). Conclusions. This study has added new evidences about potentially pancreatitis-associated drugs in literature. This is the first study to report definite 5-fluorouracil- and triamcinolone-induced AP. An updated version of the evidence-based literature review is needed to support the clinicians in the identification of the causative drugs.
format Article
id doaj-art-99f7c6dcd3f94e03a55c731ef3b10b39
institution Kabale University
issn 2291-2789
2291-2797
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology and Hepatology
spelling doaj-art-99f7c6dcd3f94e03a55c731ef3b10b392025-02-03T01:01:26ZengWileyCanadian Journal of Gastroenterology and Hepatology2291-27892291-27972020-01-01202010.1155/2020/15164931516493A Drug-Induced Acute Pancreatitis Retrospective StudyAnn-Lorie Gagnon0Alexandre Lavoie1Marie-Pier Frigon2Alban Michaud-Herbst3Karine Tremblay4Community Genomic Medicine Center, Department of Medicine, Université de Montréal and ECOGENE-21 biocluster, Chicoutimi, QC, CanadaDepartment of Pharmacy, Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay-Lac-St-Jean, Chicoutimi, QC, CanadaCommunity Genomic Medicine Center, Department of Medicine, Université de Montréal and ECOGENE-21 biocluster, Chicoutimi, QC, CanadaDepartment of Gastroenterology, Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay-Lac-St-Jean, Chicoutimi, QC, CanadaCommunity Genomic Medicine Center, Department of Medicine, Université de Montréal and ECOGENE-21 biocluster, Chicoutimi, QC, CanadaBackground and Aims. Drugs are considered a relatively rare and understudied cause of acute pancreatitis (AP). The lack of convincing and conclusive data on drug-induced AP (DIAP) complicates the diagnosis as well as the identification of the causative drug. The aim of this study is to document causes of DIAP cases that occurred in the Saguenay-Lac-Saint-Jean (SLSJ) population. Methods. We have conducted a retrospective and descriptive population-based study of DIAP cases that occurred between 2006 and 2014 in the six hospitals serving the entire SLSJ population. Cases were selected from the Quebec Ministry of Health hospitalizations registry (MED-ECHO) administrative public database. A medical chart review was performed in an attempt to characterize DIAP hospitalizations and to identify the imputable drugs. Results. During the studied period, 75 cases (30.7% male, 69.3% female) were included totaling 90 hospitalizations for DIAP. Among them, 50 causative drugs were identified and were distributed in 17 different drug classes. Recurrent DIAPs were documented in 13 cases, and among them, 6 cases have experimented a positive rechallenge. Six drugs (5-fluorouracil, atorvastatin, bortezomib, nilotinib, rosuvastatin, and triamcinolone) were associated with the highest degree of evidence. The most common causative drugs of DIAP hospitalization were azathioprine (n = 7), followed by atorvastatin (n = 6), hydrochlorothiazide (n = 5), rosuvastatin (n = 4), and codeine (n = 4). Conclusions. This study has added new evidences about potentially pancreatitis-associated drugs in literature. This is the first study to report definite 5-fluorouracil- and triamcinolone-induced AP. An updated version of the evidence-based literature review is needed to support the clinicians in the identification of the causative drugs.http://dx.doi.org/10.1155/2020/1516493
spellingShingle Ann-Lorie Gagnon
Alexandre Lavoie
Marie-Pier Frigon
Alban Michaud-Herbst
Karine Tremblay
A Drug-Induced Acute Pancreatitis Retrospective Study
Canadian Journal of Gastroenterology and Hepatology
title A Drug-Induced Acute Pancreatitis Retrospective Study
title_full A Drug-Induced Acute Pancreatitis Retrospective Study
title_fullStr A Drug-Induced Acute Pancreatitis Retrospective Study
title_full_unstemmed A Drug-Induced Acute Pancreatitis Retrospective Study
title_short A Drug-Induced Acute Pancreatitis Retrospective Study
title_sort drug induced acute pancreatitis retrospective study
url http://dx.doi.org/10.1155/2020/1516493
work_keys_str_mv AT annloriegagnon adruginducedacutepancreatitisretrospectivestudy
AT alexandrelavoie adruginducedacutepancreatitisretrospectivestudy
AT mariepierfrigon adruginducedacutepancreatitisretrospectivestudy
AT albanmichaudherbst adruginducedacutepancreatitisretrospectivestudy
AT karinetremblay adruginducedacutepancreatitisretrospectivestudy
AT annloriegagnon druginducedacutepancreatitisretrospectivestudy
AT alexandrelavoie druginducedacutepancreatitisretrospectivestudy
AT mariepierfrigon druginducedacutepancreatitisretrospectivestudy
AT albanmichaudherbst druginducedacutepancreatitisretrospectivestudy
AT karinetremblay druginducedacutepancreatitisretrospectivestudy